MIRA INFORM REPORT

 

 

Report Date :

10.06.2013

 

IDENTIFICATION DETAILS

 

Name :

SHANGHAI TOFFLON SCIENCE AND TECHNOLOGY

 

 

Registered Office :

No. 1509 Duhui Road, Minhang District  Shanghai, 201108 

 

 

Country :

China

 

 

Financials (as on) :

31.12.2012

 

 

Date of Incorporation :

25.12.1993

 

 

Legal Form :

Public Independent

 

 

Line of Business :

Subject is engaged in the research, development, design, manufacture, distribution and service of medical freeze dryers and freeze drying systems.

 

 

No. of Employees :

740

 

RATING & COMMENTS

 

MIRA’s Rating :

B

 

RATING

STATUS

PROPOSED CREDIT LINE

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

Small

 

Status :

Moderate

Payment Behaviour :

No Complaints

Litigation :

Clear

 

NOTES:

Any query related to this report can be made on e-mail: infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – March, 31st, 2013

 

Country Name

Previous Rating

(31.12.2012)

Current Rating

(31.03.2013)

China

A2

A2

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 


 

china - ECONOMIC OVERVIEW

 

Since the late 1970s China has moved from a closed, centrally planned system to a more market-oriented one that plays a major global role - in 2010 China became the world''s largest exporter. Reforms began with the phasing out of collectivized agriculture, and expanded to include the gradual liberalization of prices, fiscal decentralization, increased autonomy for state enterprises, creation of a diversified banking system, development of stock markets, rapid growth of the private sector, and opening to foreign trade and investment. China has implemented reforms in a gradualist fashion. In recent years, China has renewed its support for state-owned enterprises in sectors it considers important to "economic security," explicitly looking to foster globally competitive national champions. After keeping its currency tightly linked to the US dollar for years, in July 2005 China revalued its currency by 2.1% against the US dollar and moved to an exchange rate system that references a basket of currencies. From mid 2005 to late 2008 cumulative appreciation of the renminbi against the US dollar was more than 20%, but the exchange rate remained virtually pegged to the dollar from the onset of the global financial crisis until June 2010, when Beijing allowed resumption of a gradual appreciation. The restructuring of the economy and resulting efficiency gains have contributed to a more than tenfold increase in GDP since 1978. Measured on a purchasing power parity (PPP) basis that adjusts for price differences, China in 2012 stood as the second-largest economy in the world after the US, having surpassed Japan in 2001. The dollar values of China''s agricultural and industrial output each exceed those of the US; China is second to the US in the value of services it produces. Still, per capita income is below the world average. The Chinese government faces numerous economic challenges, including: (a) reducing its high domestic savings rate and correspondingly low domestic demand; (b) sustaining adequate job growth for tens of millions of migrants and new entrants to the work force; (c) reducing corruption and other economic crimes; and (d) containing environmental damage and social strife related to the economy''s rapid transformation. Economic development has progressed further in coastal provinces than in the interior, and by 2011 more than 250 million migrant workers and their dependents had relocated to urban areas to find work. One consequence of population control policy is that China is now one of the most rapidly aging countries in the world. Deterioration in the environment - notably air pollution, soil erosion, and the steady fall of the water table, especially in the North - is another long-term problem. China continues to lose arable land because of erosion and economic development. The Chinese government is seeking to add energy production capacity from sources other than coal and oil, focusing on nuclear and alternative energy development. In 2010-11, China faced high inflation resulting largely from its credit-fueled stimulus program. Some tightening measures appear to have controlled inflation, but GDP growth consequently slowed to under 8% for 2012. An economic slowdown in Europe contributed to China''s, and is expected to further drag Chinese growth in 2013. Debt overhang from the stimulus program, particularly among local governments, and a property price bubble challenge policy makers currently. The government''s 12th Five-Year Plan, adopted in March 2011, emphasizes continued economic reforms and the need to increase domestic consumption in order to make the economy less dependent on exports in the future. However, China has made only marginal progress toward these rebalancing goals.

Source : CIA

 


Company name and address

 

SHANGHAI TOFFLON SCIENCE AND TECHNOLOGY                

 

 

 

No. 1509 Duhui Road, Minhang District

Shanghai, 201108

China

 

 

Tel:

86-21-64909699

Fax:

86-21-64909369

 

en.tofflon.com

 

Employees:

740

Company Type:

Public Independent

Traded:

Shenzhen Stock Exchange:

300171

Incorporation Date:

25-Dec-1993

Auditor:

BDO China Shu Lun Pan CPAs

Financials in:

USD (In Millions)

Fiscal Year End:

31-Dec-2012

Reporting Currency:

Chinese Renminbi

Annual Sales:

130.2  1

Net Income:

37.0

Total Assets:

515.0  2

Market Value:

1,065.3

 

(24-May-2013)

 

 

Business Description

 

 

Shanghai Tofflon Science and Technology Co., Ltd. is principally engaged in the research, development, design, manufacture, distribution and service of medical freeze dryers and freeze drying systems. The Company primarily provides clean in place (CIP) and steam in place (SIP) freeze dryers, CIP freeze dryers, experimental freeze dryers, liquid nitrogen freeze dryers, freeze drying system equipment, as well as accessories and other equipment. The Company distributes its products in domestic markets and to overseas markets. The Company distributes its products under the brand name of Tofflon. For the fiscal year ended 31 December 2012, Shanghai Tofflon Science and Technology revenues increased 27% to RMB821.9M. Net income increased 7% to RMB233.3M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net income was partially offset by Other Finance Cost increase of 80% to RMB508K (expense), Gain on Sale of Assets decrease of 48% to RMB17K (income).

 

 

 

Industry

 

Industry

Medical Equipment and Supplies

ANZSIC 2006:

2412 - Medical and Surgical Equipment Manufacturing

NACE 2002:

3310 - Manufacture of medical and surgical equipment and orthopaedic appliances

NAICS 2002:

339113 - Surgical Appliance and Supplies Manufacturing

UK SIC 2003:

3310 - Manufacture of medical and surgical equipment and orthopaedic appliances

UK SIC 2007:

3250 - Manufacture of medical and dental instruments and supplies

US SIC 1987:

3842 - Orthopedic, Prosthetic, and Surgical Appliances and Supplies

 

 

Key Executives

 

Name

Title

Fangjun Xiong

Secretary of the Board, Deputy General Manager

Zhijun Xu

Chief Financial Officer

Jinwang Zheng

Chief Technology Officer

Xiaodong Zheng

Chairman of the Board

Zhichao Dong

Director

 

 

Significant Developments

 

Topic

#*

Most Recent Headline

Date

Other Accounting

1

Shanghai Tofflon Science and Technology Co Ltd's Subsidiary Obtains High-tech Enterprise Recognition; to Enjoy Tax Preference

19-Mar-2013

Negative Earnings Pre-Announcement

1

Shanghai Tofflon Science and Technology Co Ltd Announces FY 2012 Net Profit Outlook Below Analysts' Estimates

23-Jan-2013

Officer Changes

1

Shanghai Tofflon Science and Technology Co Ltd Announces Resignation of General Manager

29-Mar-2013

Other Earnings Pre-Announcement

1

Shanghai Tofflon Science and Technology Co Ltd Announces FY 2013 Q1 Net Profit Outlook

3-Apr-2013

Dividends

2

Shanghai Tofflon Science and Technology Co Ltd Announces FY 2012 Dividend Payment Date

29-May-2013

 

 

News

 

Title

Date

Justification and Approval - 48-- Valves
FedBizOpps (79 Words)

25-Apr-2013

CONTRACT AWARD - 48-- Valves
FedBizOpps (101 Words)

23-Apr-2013

Award Notice - Valves
FedBizOpps (55 Words)

23-Apr-2013

Shanghai Tofflon Science and Technology Co Ltd Announces FY 2012 Dividend Payment
Reuters (30 Words)

18-Apr-2013

Research Conducted at State Oceanic Administration Has Updated Our Knowledge about Ocean Research
Ecology, Environment & Conservation (361 Words)

17-Apr-2013

Shanghai Tofflon Science and Technology Co Ltd Announces Resignation of General Manager
Reuters (21 Words)

29-Mar-2013

* number of significant developments within the last 12 months

 

 

 

Financial Summary

 

As of 31-Dec-2012

Key Ratios

Company

Industry

Current Ratio (MRQ)

2.99

2.84

Quick Ratio (MRQ)

2.41

1.96

Debt to Equity (MRQ)

0.0082

0.37

Sales 5 Year Growth

37.50

13.75

Net Profit Margin (TTM) %

29.02

10.96

Return on Assets (TTM) %

8.33

7.42

Return on Equity (TTM) %

11.00

13.52

 

 

Stock Snapshot

 

Traded: Shenzhen Stock Exchange: 300171

 

As of 24-May-2013

   Financials in: CNY

Recent Price

31.42

 

EPS

1.14

52 Week High

33.19

 

Price/Sales

7.95

52 Week Low

24.02

 

Dividend Rate

0.46

Avg. Volume (mil)

1.96

 

Price/Earnings

26.69

Market Value (mil)

6,535.36

 

Price/Book

2.98

 

Price % Change

Rel S&P 500%

4 Week

18.61%

10.79%

13 Week

2.35%

3.01%

52 Week

23.78%

32.83%

Year to Date

4.94%

2.81%

 

1 - Profit & Loss Item Exchange Rate: USD 1 = CNY 6.310555
2 - Balance Sheet Item Exchange Rate: USD 1 = CNY 6.2357

 

 

Corporate Overview

 

Location
No. 1509 Duhui Road, Minhang District
Shanghai, 201108
China

 

Tel:

86-21-64909699

Fax:

86-21-64909369

 

en.tofflon.com

Quote Symbol - Exchange

300171 - Shenzhen Stock Exchange

Sales CNY(mil):

821.9

Assets CNY(mil):

3,211.5

Employees:

740

Fiscal Year End:

31-Dec-2012

 

Industry:

Medical Equipment and Supplies

Incorporation Date:

25-Dec-1993

Company Type:

Public Independent

Quoted Status:

Quoted

 

Secretary of the Board, Deputy General Manager:

Fangjun Xiong

 

 

Industry Codes

 

ANZSIC 2006 Codes:

2412

-

Medical and Surgical Equipment Manufacturing

 

NACE 2002 Codes:

3310

-

Manufacture of medical and surgical equipment and orthopaedic appliances

 

NAICS 2002 Codes:

339113

-

Surgical Appliance and Supplies Manufacturing

 

US SIC 1987:

3842

-

Orthopedic, Prosthetic, and Surgical Appliances and Supplies

 

UK SIC 2003:

3310

-

Manufacture of medical and surgical equipment and orthopaedic appliances

 

UK SIC 2007:

3250

-

Manufacture of medical and dental instruments and supplies

 

 

Business Description

 

Shanghai Tofflon Science and Technology Co., Ltd. is principally engaged in the research, development, design, manufacture, distribution and service of medical freeze dryers and freeze drying systems. The Company primarily provides clean in place (CIP) and steam in place (SIP) freeze dryers, CIP freeze dryers, experimental freeze dryers, liquid nitrogen freeze dryers, freeze drying system equipment, as well as accessories and other equipment. The Company distributes its products in domestic markets and to overseas markets. The Company distributes its products under the brand name of Tofflon. For the fiscal year ended 31 December 2012, Shanghai Tofflon Science and Technology revenues increased 27% to RMB821.9M. Net income increased 7% to RMB233.3M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net income was partially offset by Other Finance Cost increase of 80% to RMB508K (expense), Gain on Sale of Assets decrease of 48% to RMB17K (income).

 

 

Financial Data

 

Financials in:

CNY(mil)

 

Revenue:

821.9

Net Income:

233.3

Assets:

3,211.5

Long Term Debt:

0.0

 

Total Liabilities:

1,021.1

 

Working Capital:

1.9

 

 

 

Date of Financial Data:

31-Dec-2012

 

1 Year Growth

26.7%

7.3%

27.5%

 

 

Key Corporate Relationships

Auditor:

BDO China Shu Lun Pan CPAs

Auditor:

BDO China Shu Lun Pan CPAs

 

 

 

 

 

 

 

Executives Report

 

Board of Directors

Name

Title

Function

Xiaodong Zheng

 

Chairman of the Board

Chairman

Biography:

Mr. Zheng Xiaodong has been serving as Chairman of the Board in Shanghai Tofflon Science and Technology Co., Ltd. since March 28, 2013. He is also Chairman of a Shanghai-based vacuum technology company, as well as Executive Director in two Shanghai-based subsidiaries and another Shanghai-based companies, as well as Director in an air conditioner equipment subsidiary. He used to be Executive Director and General Manager in the Company's former entity.

Age: 49

Zhichao Dong

 

Director

Director/Board Member

 

Biography:

Mr. Dong Zhichao has been Director in Shanghai Tofflon Science and Technology Co.,Ltd. since January 16, 2012. He is also Vice President in a pharmaceutical development company and General Manager in an industrial park. He used to be General Manager and Chairman of the Board in a Shanghai-based pharmaceutical company, as well as Chairman of the Board in two other pharmaceutical companies.

Age: 47

Zemin Huang

 

Independent Director

Director/Board Member

 

Biography:

Mr. Huang Zemin is Independent Director in Shanghai Tofflon Science and Technology Co.,Ltd. He holds a Ph.D in Economics and he is Tenured Professor of East China Normal University. He is also Independent Director in a trust company. He used to be Independent Director in Shanghai Airlines Co., Ltd.

Age: 60

Huixing Tang

 

Deputy General Manager, Director

Director/Board Member

 

Biography:

Mr. Tang Huixing is Deputy General Manager and Director in Shanghai Tofflon Science and Technology Co.,Ltd. He is also Director in two Shanghai-based subsidiaries.

Age: 49

Changxin Wu

 

Deputy General Manager, Director

Director/Board Member

 

Biography:

Mr. Wu Changxin is Deputy General Manager and Director in Shanghai Tofflon Science and Technology Co.,Ltd. He used to be Manager of Manufacturing Center of the Company.

Age: 57

Shumin Yuan

 

Independent Director

Director/Board Member

 

Biography:

Mr. Yuan Shumin is Independent Director in Shanghai Tofflon Science and Technology Co.,Ltd. He is also Professor in Shanghai Finance University, Independent Director in Shanghai Jiaoda Withub Information Industrial Co., Ltd., SHANGHAI JIABAO INDUSTRY & COMMERCE(GROUP) CO.,LTD. and SHANGHAI MORN ELECTRIC EQUIPMENT Co., LTD. He used to be Independent Director in two other Shanghai-based companies including SHANGHIA DAJIANG (GROUP) CO.,LTD. He obtained a Master's degree in Economics from Shanghai University of Finance and Economics in 1988 and a Ph.D in Science from Fudan University in January 1998.

Age: 62

Education:

Fudan University, PHD (Science)
Shanghai University of Finance and Economics, M (Economics)
Shanghai University of Finance and Economics, B (Economics)

Haibin Zhang

 

Director

Director/Board Member

 

Age: 39

Xiaoyou Zheng

 

Deputy General Manager, Director

Director/Board Member

 

Biography:

Mr. Zheng Xiaoyou is Deputy General Manager and Director in Shanghai Tofflon Science and Technology Co.,Ltd. He is also Director in an air conditioner equipment subsidiary.

Age: 40

Daqi Zhu

 

Independent Director

Director/Board Member

 

Biography:

Mr. Zhu Daqi is Independent Director in Shanghai Tofflon Science and Technology Co.,Ltd. He holds a Ph.D in Law and he is Professor of Renmin University of China. He is also Independent Director in three companies including GAC CHANGFENG MOTOR CO.,LTD. He was Associate Professor of Renmin University of China.

Age: 45

 

Executives

 

Name

Title

Function

Cheng Chang

 

Deputy General Manager

Division Head Executive

Age: 50

Koei Nishimatsu

 

General Manager

Division Head Executive

 

Biography:

Mr. Koei Nishimatsu (was also called Xue Jiangying) has been serving as General Manager in Shanghai Tofflon Science and Technology Co., Ltd. since April 18, 2013. He served as Director in other four Shanghai-based companies and two Jiangsu-based companies. He holds his Executive Master of Business Administration (EMBA) from China Europe International Business School.

Age: 48

Education:

China Europe International Business School, MBA

Jinbo Niu

 

Deputy General Manager

Division Head Executive

 

Biography:

Mr. Niu Jinbo is Deputy General Manager in Shanghai Tofflon Science and Technology Co.,Ltd. He used to be Deputy Head of Factory in a Shanxi-based factory, as well as Deputy General Manager in another Shanxi-based company and a Shanghai-based technology company.

Age: 48

Huixing Tang

 

Deputy General Manager, Director

Division Head Executive

 

Biography:

Mr. Tang Huixing is Deputy General Manager and Director in Shanghai Tofflon Science and Technology Co.,Ltd. He is also Director in two Shanghai-based subsidiaries.

Age: 49

Changxin Wu

 

Deputy General Manager, Director

Division Head Executive

 

Biography:

Mr. Wu Changxin is Deputy General Manager and Director in Shanghai Tofflon Science and Technology Co.,Ltd. He used to be Manager of Manufacturing Center of the Company.

Age: 57

Fangjun Xiong

 

Secretary of the Board, Deputy General Manager

Division Head Executive

 

Biography:

Ms. Xiong Fangjun is Secretary of the Board and Deputy General Manager in Shanghai Tofflon Science and Technology Co.,Ltd. She used to be Project Manager and Chief Administrative Officer in a Henan-based real estate consulting company, as well as Manager-Marketing in a Shanghai-based industry investment company.

Age: 41

Xiaoyou Zheng

 

Deputy General Manager, Director

Division Head Executive

 

Biography:

Mr. Zheng Xiaoyou is Deputy General Manager and Director in Shanghai Tofflon Science and Technology Co.,Ltd. He is also Director in an air conditioner equipment subsidiary.

Age: 40

Zhijun Xu

 

Chief Financial Officer

Finance Executive

 

Biography:

Mr. Xu Zhijun has been Chief Financial Officer in Shanghai Tofflon Science and Technology Co.,Ltd since March 8, 2012. He used to be Deputy Manager-Finance in a department store and Manager-Finance in a Shanghai-based company.

Age: 44

Jinwang Zheng

 

Chief Technology Officer

Engineering/Technical Executive

 

Biography:

Mr. Zheng Jinwang is Chief Technology Officer in Shanghai Tofflon Science and Technology Co.,Ltd. He is also Director in a technology subsidiary. He used to be Technology Manager in the Company's former entity.

Age: 36

Jie Yin

 

Director of Research and Development

Research & Development Executive

 

Biography:

Mr. Yin Jie is Director of Research and Development in Shanghai Tofflon Science and Technology Co.,Ltd. He used to be Business Manager in a Nanjing-based company, as well as Manager-Production in a Beijing-based technology company.

Age: 50

 

 

Significant Developments

 

 

 

Shanghai Tofflon Science and Technology Co Ltd Announces FY 2012 Dividend Payment Date

May 29, 2013


Shanghai Tofflon Science and Technology Co Ltd announced that it will pay cash dividend of RMB 5 per 10 shares (before tax) for fiscal year 2012, to shareholders of record on June 5, 2013. The Company's shares will be traded ex-dividend on June 3, 2013 and the dividend will be paid on June 6, 2013.

Shanghai Tofflon Science and Technology Co Ltd Announces FY 2012 Dividend Payment

Apr 18, 2013


Shanghai Tofflon Science and Technology Co Ltd announced that it will pay cash dividend of RMB 5 per 10 shares (before tax) to the Company's shareholders for fiscal year 2012.

Shanghai Tofflon Science and Technology Co Ltd Announces FY 2013 Q1 Net Profit Outlook

Apr 03, 2013


Shanghai Tofflon Science and Technology Co Ltd announced that it expects its net profit for the first quarter of fiscal year (FY) 2013 to increase by 10%-30%or to be RMB 58,608,000-RMB 69,264,000, compared to the net profit of the same period in FY 2012 (RMB 53,280,000). The Company cited the increased orders and the contribution of subsidiaries as the main reason for the forecast.

Shanghai Tofflon Science and Technology Co Ltd Announces Resignation of General Manager

Mar 29, 2013


Shanghai Tofflon Science and Technology Co Ltd announced the resignation of Mr. Zheng Xiaodong as General Manager, effective March 28, 2013.

Shanghai Tofflon Science and Technology Co Ltd's Subsidiary Obtains High-tech Enterprise Recognition; to Enjoy Tax Preference

Mar 19, 2013


Shanghai Tofflon Science and Technology Co Ltd announced that its subsidiary, a Shagnhai-based vacuum technology company, was recognized as high-tech enterprise, and will enjoy an income tax rate of 15% from fiscal year 2012 to 2014.

Shanghai Tofflon Science and Technology Co Ltd Announces FY 2012 Net Profit Outlook Below Analysts' Estimates

Jan 23, 2013


Shanghai Tofflon Science and Technology Co Ltd announced that it expects its net profit for fiscal year (FY) 2012 to be approximately RMB 217,402,500 to RMB 260,883,000, or to increase by 0%-20%, compared to that of FY 2011 (RMB 217,402,500). The Company cited the increased business income as the main reason for this forecast. According to I/B/E/S Estimates, analysts expect the Company's net profit for fiscal year 2012 to be RMB 263.08 million.

 

News

 

Justification and Approval - 48-- Valves
FedBizOpps (79 Words)

25-Apr-2013

CONTRACT AWARD - 48-- Valves
FedBizOpps (101 Words)

23-Apr-2013

Award Notice - Valves
FedBizOpps (55 Words)

23-Apr-2013

Shanghai Tofflon Science and Technology Co Ltd Announces FY 2012 Dividend Payment
Reuters (30 Words)

18-Apr-2013

Research Conducted at State Oceanic Administration Has Updated Our Knowledge about Ocean Research
Ecology, Environment & Conservation (361 Words)

17-Apr-2013

Shanghai Tofflon Science and Technology Co Ltd Announces Resignation of General Manager
Reuters (21 Words)

29-Mar-2013

China Pharmaceutical Equipment Industry Report, 2012-2015
SBWire (416 Words)

25-Mar-2013

Pharma equipment industry in China showing steady growth, finds report
Manufacturing Chemist (171 Words)

20-Mar-2013

China pharmaceutical equipment market: Sales forecast to total RMB31.41Bn by the end of 2015 (companiesandmarkets.com)
Presscontacts.com (311 Words)

18-Mar-2013

China pharmaceutical equipment market: Sales forecast to total RMB31.41Bn by the end of 2015
MyNewsDesk (300 Words)

18-Mar-2013

China Pharmaceutical Equipment Industry Report, 2012-2015
MarketResearch.com (361 Words)

13-Mar-2013

 

Annual Income Statement

 

Financials in: USD (mil) 

Except for share items (millions) and per share items (actual units)         

 

 

31-Dec-2012

31-Dec-2011

31-Dec-2010

31-Dec-2009

31-Dec-2008

Period Length

12 Months

12 Months

12 Months

12 Months

12 Months

UpdateType/Date

Updated Normal
31-Dec-2012

Updated Normal
31-Dec-2011

Updated Normal
31-Dec-2010

Updated Normal
30-Jun-2010

Updated Normal
30-Jun-2010

Filed Currency

CNY

CNY

CNY

CNY

CNY

Exchange Rate (Period Average)

6.310555

6.46438

6.768989

6.831007

6.950445

Auditor

BDO China Shu Lun Pan CPAs

BDO China Shu Lun Pan CPAs

BDO China Shu Lun Pan CPAs

BDO China Shu Lun Pan CPAs

BDO China Shu Lun Pan CPAs

Auditor Opinion

Unqualified

Unqualified

Unqualified

Unqualified

Unqualified

 

 

 

 

 

 

    Net Sales

130.2

100.4

71.0

45.1

31.1

Revenue

130.2

100.4

71.0

45.1

31.1

Total Revenue

130.2

100.4

71.0

45.1

31.1

 

 

 

 

 

 

    Cost of Revenue

70.9

52.1

37.0

25.2

18.6

Cost of Revenue, Total

70.9

52.1

37.0

25.2

18.6

Gross Profit

59.3

48.3

34.0

19.9

12.6

 

 

 

 

 

 

    Selling/General/Administrative Expense

9.2

15.7

10.8

7.3

5.0

    Labor & Related Expense

4.5

-

-

-

-

    Advertising Expense

1.9

-

-

-

-

Total Selling/General/Administrative Expenses

15.6

15.7

10.8

7.3

5.0

Research & Development

7.4

-

-

-

-

    Depreciation

0.8

-

-

-

-

    Amortization of Intangibles

0.5

-

-

-

-

Depreciation/Amortization

1.3

-

-

-

-

        Interest Expense - Operating

0.1

0.1

0.0

0.1

0.1

    Interest Expense - Net Operating

0.1

0.1

0.0

0.1

0.1

        Interest Income - Operating

-7.6

-7.0

-0.3

-0.2

-0.2

        Investment Income - Operating

-0.1

0.0

0.2

0.1

-0.3

    Interest/Investment Income - Operating

-7.7

-7.0

-0.1

-0.1

-0.5

Interest Expense (Income) - Net Operating Total

-7.6

-6.8

-0.1

0.0

-0.4

    Impairment-Assets Held for Use

0.7

1.1

0.0

0.2

-0.2

Unusual Expense (Income)

0.7

1.1

0.0

0.2

-0.2

    Other Operating Expense

0.1

0.0

0.0

0.0

0.0

Other Operating Expenses, Total

0.1

0.0

0.0

0.0

0.0

Total Operating Expense

88.5

62.1

47.7

32.6

23.0

 

 

 

 

 

 

Operating Income

41.7

38.3

23.3

12.4

8.1

 

 

 

 

 

 

Gain (Loss) on Sale of Assets

0.0

0.0

-

0.0

0.0

    Other Non-Operating Income (Expense)

2.7

1.2

1.4

0.8

0.7

Other, Net

2.7

1.2

1.4

0.8

0.7

Income Before Tax

44.5

39.5

24.7

13.3

8.8

 

 

 

 

 

 

Total Income Tax

6.7

5.5

3.6

1.8

1.2

Income After Tax

37.8

34.0

21.1

11.5

7.6

 

 

 

 

 

 

    Minority Interest

-0.8

-0.3

0.0

-0.4

0.1

Net Income Before Extraord Items

37.0

33.6

21.1

11.1

7.7

Net Income

37.0

33.6

21.1

11.1

7.7

 

 

 

 

 

 

Income Available to Common Excl Extraord Items

37.0

33.6

21.1

11.1

7.7

 

 

 

 

 

 

Income Available to Common Incl Extraord Items

37.0

33.6

21.1

11.1

7.7

 

 

 

 

 

 

Basic/Primary Weighted Average Shares

208.0

203.7

156.0

156.0

156.0

Basic EPS Excl Extraord Items

0.18

0.17

0.14

0.07

0.05

Basic/Primary EPS Incl Extraord Items

0.18

0.17

0.14

0.07

0.05

Dilution Adjustment

0.0

-

-

-

-

Diluted Net Income

37.0

33.6

21.1

11.1

7.7

Diluted Weighted Average Shares

208.0

203.7

156.0

156.0

156.0

Diluted EPS Excl Extraord Items

0.18

0.17

0.14

0.07

0.05

Diluted EPS Incl Extraord Items

0.18

0.17

0.14

0.07

0.05

Dividends per Share - Common Stock Primary Issue

-

0.07

0.00

0.00

0.00

Gross Dividends - Common Stock

-

14.9

0.0

0.0

0.0

Interest Expense, Supplemental

0.1

0.1

0.0

0.1

0.1

Depreciation, Supplemental

1.8

1.1

0.9

0.7

0.6

Total Special Items

0.7

1.1

0.0

0.1

-0.2

Normalized Income Before Tax

45.2

40.6

24.7

13.4

8.6

 

 

 

 

 

 

Effect of Special Items on Income Taxes

0.1

0.2

0.0

0.0

0.0

Inc Tax Ex Impact of Sp Items

6.8

5.7

3.6

1.8

1.2

Normalized Income After Tax

38.4

34.9

21.1

11.6

7.5

 

 

 

 

 

 

Normalized Inc. Avail to Com.

37.6

34.6

21.1

11.2

7.5

 

 

 

 

 

 

Basic Normalized EPS

0.18

0.17

0.14

0.07

0.05

Diluted Normalized EPS

0.18

0.17

0.14

0.07

0.05

Amort of Intangibles, Supplemental

0.5

0.2

0.1

0.1

0.1

Rental Expenses

0.1

0.1

0.0

0.0

0.0

Advertising Expense, Supplemental

1.9

-

-

-

-

Research & Development Exp, Supplemental

7.4

6.1

3.7

2.4

1.2

Normalized EBIT

34.9

32.5

23.2

12.6

7.5

Normalized EBITDA

37.3

33.9

24.3

13.3

8.1

    Current Tax - Total

-

5.7

3.6

1.9

1.2

Current Tax - Total

-

5.7

3.6

1.9

1.2

    Deferred Tax - Total

-

-0.2

0.0

-0.1

0.0

Deferred Tax - Total

-

-0.2

0.0

-0.1

0.0

Income Tax - Total

-

5.5

3.6

1.8

1.2

 

 

Annual Balance Sheet

 

Financials in: USD (mil)

 

 

 

31-Dec-2012

31-Dec-2011

31-Dec-2010

31-Dec-2009

31-Dec-2008

UpdateType/Date

Updated Normal
31-Dec-2012

Updated Normal
31-Dec-2011

Updated Normal
31-Dec-2010

Updated Normal
30-Jun-2010

Updated Normal
30-Jun-2010

Filed Currency

CNY

CNY

CNY

CNY

CNY

Exchange Rate

6.2357

6.294

6.5897

6.827

6.823

Auditor

BDO China Shu Lun Pan CPAs

BDO China Shu Lun Pan CPAs

BDO China Shu Lun Pan CPAs

BDO China Shu Lun Pan CPAs

BDO China Shu Lun Pan CPAs

Auditor Opinion

Unqualified

Unqualified

Unqualified

Unqualified

Unqualified

 

 

 

 

 

 

    Cash & Equivalents

313.8

273.7

37.6

25.0

14.7

Cash and Short Term Investments

313.8

273.7

37.6

25.0

14.7

        Accounts Receivable - Trade, Gross

-

17.8

9.6

6.1

4.2

        Provision for Doubtful Accounts

-

-2.2

-1.1

-1.0

-0.9

    Trade Accounts Receivable - Net

21.5

15.6

8.5

5.1

3.3

    Notes Receivable - Short Term

24.0

7.9

9.9

5.1

1.8

    Other Receivables

9.0

4.9

0.0

0.3

0.3

Total Receivables, Net

54.5

28.5

18.4

10.5

5.4

    Inventories - Finished Goods

-

20.6

28.8

15.0

11.4

    Inventories - Work In Progress

-

26.6

15.8

7.6

8.7

    Inventories - Raw Materials

-

7.1

6.4

4.1

2.6

Total Inventory

89.6

54.3

51.0

26.8

22.8

Prepaid Expenses

7.0

7.8

2.5

5.6

0.9

Total Current Assets

464.9

364.4

109.6

67.9

43.8

 

 

 

 

 

 

        Buildings

-

7.8

7.4

7.2

-

        Machinery/Equipment

-

7.5

4.9

3.1

-

    Property/Plant/Equipment - Gross

-

15.3

12.3

10.3

-

    Accumulated Depreciation

-

-4.1

-3.0

-2.0

-

Property/Plant/Equipment - Net

33.3

24.4

11.0

8.2

6.4

Goodwill, Net

2.0

0.0

0.0

0.0

0.0

Intangibles, Net

14.0

10.6

5.9

2.5

2.5

    Deferred Charges

0.2

0.2

-

-

-

    Deferred Income Tax - Long Term Asset

0.6

0.4

0.2

0.2

0.1

Other Long Term Assets, Total

0.8

0.6

0.2

0.2

0.1

Total Assets

515.0

400.1

126.7

78.9

52.9

 

 

 

 

 

 

Accounts Payable

20.2

6.8

5.3

3.3

2.5

Accrued Expenses

0.8

0.3

0.1

0.3

0.2

Notes Payable/Short Term Debt

2.9

0.0

2.4

0.0

0.0

Current Portion - Long Term Debt/Capital Leases

-

-

-

-

0.7

    Dividends Payable

0.0

-

-

-

-

    Customer Advances

137.1

65.9

70.1

44.2

26.4

    Income Taxes Payable

-5.5

-5.4

-3.5

-1.5

0.4

Other Current liabilities, Total

131.6

60.4

66.5

42.6

26.8

Total Current Liabilities

155.6

67.6

74.4

46.2

30.2

 

 

 

 

 

 

    Long Term Debt

-

-

-

-

0.7

Total Long Term Debt

0.0

0.0

0.0

0.0

0.7

Total Debt

2.9

0.0

2.4

0.0

1.5

 

 

 

 

 

 

Minority Interest

5.9

4.1

0.4

0.7

0.6

    Other Long Term Liabilities

2.3

2.3

1.8

1.7

0.3

Other Liabilities, Total

2.3

2.3

1.8

1.7

0.3

Total Liabilities

163.8

73.9

76.7

48.6

31.9

 

 

 

 

 

 

    Common Stock

33.4

25.4

9.1

8.8

8.8

Common Stock

33.4

25.4

9.1

8.8

8.8

Additional Paid-In Capital

242.1

247.5

6.0

5.7

5.7

Retained Earnings (Accumulated Deficit)

75.8

53.3

34.9

15.8

6.5

    Translation Adjustment

0.0

0.0

0.0

0.0

0.0

Other Equity, Total

0.0

0.0

0.0

0.0

0.0

Total Equity

351.3

326.2

50.0

30.3

21.0

 

 

 

 

 

 

Total Liabilities & Shareholders’ Equity

515.0

400.1

126.7

78.9

52.9

 

 

 

 

 

 

    Shares Outstanding - Common Stock Primary Issue

208.0

208.0

156.0

156.0

156.0

Total Common Shares Outstanding

208.0

208.0

156.0

156.0

156.0

Treasury Shares - Common Stock Primary Issue

0.0

0.0

0.0

0.0

0.0

Employees

-

740

684

466

349

Number of Common Shareholders

-

4,685

-

-

-

Accumulated Intangible Amort, Suppl.

-

0.7

0.4

0.3

-

Deferred Revenue - Current

137.1

65.9

70.1

44.2

26.4

 

 

Annual Cash Flows

 

Financials in: USD (mil)

 

 

 

31-Dec-2012

31-Dec-2011

31-Dec-2010

31-Dec-2009

31-Dec-2008

Period Length

12 Months

12 Months

12 Months

12 Months

12 Months

UpdateType/Date

Updated Normal
31-Dec-2012

Updated Normal
31-Dec-2011

Updated Normal
31-Dec-2010

Updated Normal
30-Jun-2010

Updated Normal
30-Jun-2010

Filed Currency

CNY

CNY

CNY

CNY

CNY

Exchange Rate (Period Average)

6.310555

6.46438

6.768989

6.831007

6.950445

Auditor

BDO China Shu Lun Pan CPAs

BDO China Shu Lun Pan CPAs

BDO China Shu Lun Pan CPAs

BDO China Shu Lun Pan CPAs

BDO China Shu Lun Pan CPAs

Auditor Opinion

Unqualified

Unqualified

Unqualified

Unqualified

Unqualified

 

 

 

 

 

 

Cash Receipts

192.6

103.4

98.8

63.2

46.7

Cash Payments

-106.6

-65.6

-69.7

-36.1

-33.1

Cash Taxes Paid

-9.7

-15.0

-6.9

-5.7

-3.3

    Other Operating Cash Flow

-21.2

-5.2

-4.7

-3.9

-2.2

Changes in Working Capital

-21.2

-5.2

-4.7

-3.9

-2.2

Cash from Operating Activities

55.0

17.6

17.5

17.4

8.1

 

 

 

 

 

 

    Purchase of Fixed Assets

-7.3

-23.0

-3.7

-5.9

-3.0

Capital Expenditures

-7.3

-23.0

-3.7

-5.9

-3.0

    Sale of Fixed Assets

0.0

0.0

-

0.1

0.0

    Sale/Maturity of Investment

-

-

-

-

0.1

    Purchase of Investments

-1.6

-

0.0

-

-

    Other Investing Cash Flow

99.2

-112.9

-

1.5

1.7

Other Investing Cash Flow Items, Total

97.6

-112.9

0.0

1.5

1.8

Cash from Investing Activities

90.3

-135.9

-3.7

-4.4

-1.2

 

 

 

 

 

 

    Other Financing Cash Flow

0.8

246.2

0.1

-

0.1

Financing Cash Flow Items

0.8

246.2

0.1

-

0.1

    Cash Dividends Paid - Common

-15.6

-10.0

-3.4

-2.1

-6.6

Total Cash Dividends Paid

-15.6

-10.0

-3.4

-2.1

-6.6

    Total Debt Issued

2.9

-

2.4

-

1.4

    Total Debt Reduction

-

-2.5

-

-1.5

-

Issuance (Retirement) of Debt, Net

2.9

-2.5

2.4

-1.5

1.4

Cash from Financing Activities

-11.9

233.7

-1.0

-3.5

-5.1

 

 

 

 

 

 

Foreign Exchange Effects

0.1

0.0

-0.2

-0.1

0.0

Net Change in Cash

133.5

115.3

12.6

9.4

1.8

 

 

 

 

 

 

Net Cash - Beginning Balance

156.9

37.9

23.6

14.0

11.9

Net Cash - Ending Balance

290.5

153.2

36.2

23.4

13.7

Depreciation

1.8

1.1

0.9

0.7

0.6

 

 

Annual Income Statement

 

Financials in: USD (mil) 

Except for share items (millions) and per share items (actual units)

           

 

 

31-Dec-2012

31-Dec-2011

31-Dec-2010

31-Dec-2009

31-Dec-2008

Period Length

12 Months

12 Months

12 Months

12 Months

12 Months

UpdateType/Date

Updated Normal
31-Dec-2012

Updated Normal
31-Dec-2011

Updated Normal
31-Dec-2010

Updated Normal
30-Jun-2010

Updated Normal
30-Jun-2010

Filed Currency

CNY

CNY

CNY

CNY

CNY

Exchange Rate (Period Average)

6.310555

6.46438

6.768989

6.831007

6.950445

Auditor

BDO China Shu Lun Pan CPAs

BDO China Shu Lun Pan CPAs

BDO China Shu Lun Pan CPAs

BDO China Shu Lun Pan CPAs

BDO China Shu Lun Pan CPAs

Auditor Opinion

Unqualified

Unqualified

Unqualified

Unqualified

Unqualified

 

 

 

 

 

 

    Other Rev from Biz Related Activ.

0.3

-

-

-

-

    Other In Operating Income

130.0

-

-

-

-

    In Operating Income

-

100.4

71.0

45.1

31.1

Total Revenue

130.2

100.4

71.0

45.1

31.1

 

 

 

 

 

 

    Advertising Expenses

1.9

-

-

-

-

    Labor & Related Expenses in SGA

4.5

-

-

-

-

    Amortisation of Intangibles

0.5

-

-

-

-

    Research & Development Expense

7.4

-

-

-

-

    Depreciation in SGA

0.0

-

-

-

-

    Depreciation in SGA

0.8

-

-

-

-

    Other Business Tax and Surcharges

0.3

-

-

-

-

    Cost of Sales

70.6

51.5

36.7

24.8

18.5

    Business Tax and Surcharges

-

0.5

0.3

0.3

0.1

    Urban Construction

0.4

-

-

-

-

    Education Tax

0.4

-

-

-

-

    Rental Expense

0.1

-

-

-

-

    Other General & Administrative Expenses

3.8

-

-

-

-

    Other Selling Expense

4.4

-

-

-

-

    Selling Expense

-

4.2

3.7

2.7

1.9

    General & Administrative Expenses

-

11.5

7.1

4.6

3.1

    Interest Expense

0.1

0.1

0.0

0.1

0.1

    Interest Income

-7.6

-7.0

-0.3

-0.2

-0.2

    Foreign Exchange Gain/Loss

-0.1

0.0

0.2

0.1

0.0

    Other Finance Cost

0.1

0.0

0.0

0.0

0.0

    Impairment Loss on Assets

0.7

1.1

0.0

0.2

-0.2

    Investment Income

-

-

-

0.0

-0.3

Total Operating Expense

88.5

62.1

47.7

32.6

23.0

 

 

 

 

 

 

    Gain on Sale of Assets

0.0

0.0

-

0.0

0.0

    Other Non - Operating Expense

-0.1

-

-

-

-

    Other Non - Operating Income

2.8

-

-

-

-

    Non - Operating Income

-

1.3

1.5

0.8

0.8

    Loss on Sale of Assets

0.0

0.0

-

-

-

    Non - Operating Expense

-

0.0

-0.1

0.0

-0.1

Net Income Before Taxes

44.5

39.5

24.7

13.3

8.8

 

 

 

 

 

 

Provision for Income Taxes

6.7

5.5

3.6

1.8

1.2

Net Income After Taxes

37.8

34.0

21.1

11.5

7.6

 

 

 

 

 

 

    Minority interests

-0.8

-

-

-

-

    Minority Interest

-

-0.3

0.0

-0.4

0.1

Net Income Before Extra. Items

37.0

33.6

21.1

11.1

7.7

Net Income

37.0

33.6

21.1

11.1

7.7

 

 

 

 

 

 

Income Available to Com Excl ExtraOrd

37.0

33.6

21.1

11.1

7.7

 

 

 

 

 

 

Income Available to Com Incl ExtraOrd

37.0

33.6

21.1

11.1

7.7

 

 

 

 

 

 

Basic Weighted Average Shares

208.0

203.7

156.0

156.0

156.0

Basic EPS Excluding ExtraOrdinary Items

0.18

0.17

0.14

0.07

0.05

Basic EPS Including ExtraOrdinary Items

0.18

0.17

0.14

0.07

0.05

Dilution Adjustment

-

-

-

-

-

Diluted Net Income

37.0

33.6

21.1

11.1

7.7

Diluted Weighted Average Shares

208.0

203.7

156.0

156.0

156.0

Diluted EPS Excluding ExtraOrd Items

0.18

0.17

0.14

0.07

0.05

Diluted EPS Including ExtraOrd Items

0.18

0.17

0.14

0.07

0.05

DPS-A Share

-

0.07

0.00

0.00

0.00

Gross Dividends - Common Stock

-

14.9

0.0

0.0

0.0

Normalized Income Before Taxes

45.2

40.6

24.7

13.4

8.6

 

 

 

 

 

 

Inc Tax Ex Impact of Sp Items

6.8

5.7

3.6

1.8

1.2

Normalized Income After Taxes

38.4

34.9

21.1

11.6

7.5

 

 

 

 

 

 

Normalized Inc. Avail to Com.

37.6

34.6

21.1

11.2

7.5

 

 

 

 

 

 

Basic Normalized EPS

0.18

0.17

0.14

0.07

0.05

Diluted Normalized EPS

0.18

0.17

0.14

0.07

0.05

Advertising Expenses

1.9

-

-

-

-

Interest Expense

0.1

-

-

-

-

Interest Expense, Supplemental

-

0.1

0.0

0.1

0.1

Research & Development Exp, Supplemental

7.4

6.1

3.7

2.4

1.2

Rental Expense, Supplemental

0.1

0.1

0.0

0.0

0.0

Depreciation, Supplemental

1.8

1.1

0.9

0.7

0.6

Amort of Intangibles, Supplemental

0.5

0.2

0.1

0.1

0.1

    Current Tax

-

5.7

3.6

1.9

1.2

Current Tax - Total

-

5.7

3.6

1.9

1.2

    Deferred Tax

-

-0.2

0.0

-0.1

0.0

Deferred Tax - Total

-

-0.2

0.0

-0.1

0.0

Income Tax - Total

-

5.5

3.6

1.8

1.2

 

spacebar

 

 

Annual Balance Sheet

Financials in: USD (mil)

 

 

 

 

 

31-Dec-2012

31-Dec-2011

31-Dec-2010

31-Dec-2009

31-Dec-2008

UpdateType/Date

Updated Normal
31-Dec-2012

Updated Normal
31-Dec-2011

Updated Normal
31-Dec-2010

Updated Normal
30-Jun-2010

Updated Normal
30-Jun-2010

Filed Currency

CNY

CNY

CNY

CNY

CNY

Exchange Rate

6.2357

6.294

6.5897

6.827

6.823

Auditor

BDO China Shu Lun Pan CPAs

BDO China Shu Lun Pan CPAs

BDO China Shu Lun Pan CPAs

BDO China Shu Lun Pan CPAs

BDO China Shu Lun Pan CPAs

Auditor Opinion

Unqualified

Unqualified

Unqualified

Unqualified

Unqualified

 

 

 

 

 

 

    Monetary capital

313.8

273.7

37.6

25.0

14.7

    Notes Receivable

24.0

7.9

9.9

5.1

1.8

    Accounts Receivable, Net

21.5

-

-

-

-

    Accounts Receivable, Gross

-

17.8

9.6

6.1

4.2

    Provision for Doubtful Accounts

-

-2.2

-1.1

-1.0

-0.9

    Payment in Advance

7.0

7.8

2.5

5.6

0.9

    Other Receivables

0.2

0.1

0.0

0.3

0.3

    Inventory, Net

89.6

-

-

-

-

    Raw Material

-

7.1

6.4

4.1

2.6

    Work-in-Process

-

26.6

15.8

7.6

8.7

    Stored Goods

-

-

-

-

0.2

    Products in Transit

-

20.6

28.8

15.0

11.2

    Interest receivable

8.8

4.8

-

-

-

Total Current Assets

464.9

364.4

109.6

67.9

43.8

 

 

 

 

 

 

    Fixed assets

32.8

-

-

-

4.3

    Buildings & Structures

-

7.8

7.4

7.2

-

    Machinery and Equipment

-

5.7

3.5

2.0

-

    Transportation Equipment

-

1.0

0.7

0.5

-

    General Equipment

-

0.8

0.7

0.6

-

    Accumulated Depreciation

-

-4.1

-3.0

-2.0

-

    Construction in Progress

0.5

13.2

1.7

-

2.1

    Intangible Assets, Net

14.0

10.6

5.9

2.5

2.5

    Goodwill, Net

2.0

0.0

0.0

0.0

0.0

    Deferred Tax Assets

0.6

0.4

0.2

0.2

0.1

    Long-term prepaid expenses

0.2

0.2

-

-

-

Total Assets

515.0

400.1

126.7

78.9

52.9

 

 

 

 

 

 

    Short Term Borrowing

2.9

-

2.4

-

-

    Accounts Payable

20.2

6.8

5.3

3.3

2.5

    Advance receipts

137.1

65.9

70.1

44.2

26.4

    Accrued Payroll

0.2

0.1

0.1

0.1

0.1

    Tax Payable

-5.5

-5.4

-3.5

-1.5

0.4

    Dividend Payable

0.0

-

-

-

-

    Other Creditors

0.7

0.2

0.0

0.2

0.2

    Current Portion of LT Debt

-

-

-

-

0.7

Total Current Liabilities

155.6

67.6

74.4

46.2

30.2

 

 

 

 

 

 

    Long Term Borrowing

-

-

-

-

0.7

Total Long Term Debt

-

-

-

-

0.7

 

 

 

 

 

 

    Estimated Liabilities

0.5

0.5

0.4

0.2

0.2

    Other Non-current Liabilities

1.8

1.8

1.5

1.5

0.2

    Minority Interest

5.9

4.1

0.4

0.7

0.6

Total Liabilities

163.8

73.9

76.7

48.6

31.9

 

 

 

 

 

 

    Capital Stock

33.4

25.4

9.1

8.8

8.8

    Paid in Capital

242.1

247.5

6.0

5.7

5.7

    Surplus Reserve

11.5

7.8

4.2

1.9

0.8

    Retained profits

64.3

45.5

30.7

13.9

5.7

    Translation Adjustments

0.0

0.0

0.0

0.0

0.0

Total Equity

351.3

326.2

50.0

30.3

21.0

 

 

 

 

 

 

Total Liabilities & Shareholders' Equity

515.0

400.1

126.7

78.9

52.9

 

 

 

 

 

 

    S/O-A Share

208.0

208.0

156.0

156.0

156.0

Total Common Shares Outstanding

208.0

208.0

156.0

156.0

156.0

T/S-A Share

0.0

0.0

0.0

0.0

0.0

Customer Advance

137.1

65.9

70.1

44.2

26.4

Accumulated Intangible Amort, Suppl.

-

0.7

0.4

0.3

-

Full-Time Employees

-

740

684

466

349

Number of Common Shareholders

-

4,685

-

-

-

 

 

Annual Cash Flows

 

Financials in: USD (mil)

 

 

 

31-Dec-2012

31-Dec-2011

31-Dec-2010

31-Dec-2009

31-Dec-2008

Period Length

12 Months

12 Months

12 Months

12 Months

12 Months

UpdateType/Date

Updated Normal
31-Dec-2012

Updated Normal
31-Dec-2011

Updated Normal
31-Dec-2010

Updated Normal
30-Jun-2010

Updated Normal
30-Jun-2010

Filed Currency

CNY

CNY

CNY

CNY

CNY

Exchange Rate (Period Average)

6.310555

6.46438

6.768989

6.831007

6.950445

Auditor

BDO China Shu Lun Pan CPAs

BDO China Shu Lun Pan CPAs

BDO China Shu Lun Pan CPAs

BDO China Shu Lun Pan CPAs

BDO China Shu Lun Pan CPAs

Auditor Opinion

Unqualified

Unqualified

Unqualified

Unqualified

Unqualified

 

 

 

 

 

 

    Cash from Sale of Goods & Services

192.6

103.4

98.8

63.2

46.7

    Cash Paid for Goods and Services

-106.6

-65.6

-69.7

-36.1

-33.1

    Tax rebates received

0.8

0.2

-

0.3

-

    Cash Paid to/for Employees

-14.7

-

-

-

-

    Other Cash from Operating Activities

6.9

3.9

2.1

0.9

1.3

    All Taxes Paid

-10.6

-15.2

-6.9

-6.0

-3.3

    Other Cash Paid for Operating Activities

-13.3

-9.2

-6.8

-4.8

-3.5

Cash from Operating Activities

55.0

17.6

17.5

17.4

8.1

 

 

 

 

 

 

    Sale/Maturity/Redemption of Investments

-

-

-

-

0.1

    Other Cash from Investing Activities

99.2

-

-

-

-

    Cash from Return on Investments

-

-

-

-

0.2

    Sale of FA/Intangibles/Other Assets

0.0

-

-

-

-

    Net cash from disposal of fixed assets,

-

0.0

-

0.1

0.0

    Cash paid for other investing activities

-

-112.9

-

1.5

1.6

    Capital Expenditure

-7.3

-23.0

-3.7

-5.9

-3.0

    Cash Paid for Purchase of Investments

-1.6

-

0.0

-

-

Cash from Investing Activities

90.3

-135.9

-3.7

-4.4

-1.2

 

 

 

 

 

 

    Cash from Investors

0.8

-

-

-

-

    Cash received from capital contributions

-

246.2

-

-

0.1

    Cash from Borrowings

2.9

-

2.4

-

1.4

    Cash repayments of amounts borrowed

-

-2.5

-

-1.5

-

    Cash Paid for Dividend and Interest

-15.6

-10.0

-3.4

-2.1

-6.6

    Other Cash from Financing Activities

-

-

0.1

-

-

Cash from Financing Activities

-11.9

233.7

-1.0

-3.5

-5.1

 

 

 

 

 

 

Foreign Exchange Effects

0.1

0.0

-0.2

-0.1

0.0

Net Change in Cash

133.5

115.3

12.6

9.4

1.8

 

 

 

 

 

 

Balance of cash and cash equivalents - B

156.9

37.9

23.6

14.0

11.9

Balance of cash and cash equivalents - E

290.5

153.2

36.2

23.4

13.7

    Depreciation

1.8

1.1

0.9

0.7

0.6

    Amortization of Intangibles

0.5

0.2

0.1

0.1

0.1

 

 

Financial Health

 

Financials in: USD (mil) 

Except for share items (millions) and per share items (actual units)         

 

Key Indicators USD (mil)

 

Quarter
Ending
31-Mar-2013

Quarter
Ending
Yr Ago

Annual
Year End
31-Dec-2012

1 Year
Growth

3 Year
Growth

5 Year
Growth

Total Revenue1 (?)

0.0

-99.85%

130.2

26.66%

38.69%

37.50%

Research & Development1 (?)

-

-

7.4

-

-

-

Operating Income1 (?)

-

-

41.7

6.51%

45.78%

40.03%

Income Available to Common Excl Extraord Items1 (?)

-

-

37.0

7.33%

45.42%

38.38%

Basic EPS Excl Extraord Items1 (?)

-

-

0.18

5.10%

32.12%

30.52%

Capital Expenditures2 (?)

-

-

7.3

-68.82%

4.55%

35.35%

Cash from Operating Activities2 (?)

0.0

-

55.0

206.13%

42.87%

60.79%

Free Cash Flow (?)

0.0

-

48.3

-

56.48%

68.56%

Total Assets3 (?)

0.5

-99.87%

515.0

27.52%

81.31%

64.43%

Total Liabilities3 (?)

0.2

-99.79%

163.8

119.46%

45.46%

46.09%

Total Long Term Debt3 (?)

-

-

0.0

-

-

-

Total Common Shares Outstanding3 (?)

-

-

208.0

0.00%

10.06%

21.67%

1-ExchangeRate: CNY to USD Average for Period

6.226074

 

6.310555

 

 

 

2-ExchangeRate: CNY to USD Average for Period

6.226074

 

6.310555

 

 

 

3-ExchangeRate: CNY to USD Period End Date

6.215888

 

6.235700

 

 

 

Utility Industry Specific USD (mil)

 

31-Dec-2012

31-Dec-2011

 

 

 

 

Deferred Charges3 (?)

0.2

0.2

 

 

 

 

3-ExchangeRate: CNY to USD Period End Date

6.235700

6.294000

 

 

 

 

Key Ratios

 

31-Dec-2012

31-Dec-2011

31-Dec-2010

31-Dec-2009

31-Dec-2008

Profitability

Gross Margin (?)

45.54%

48.13%

47.95%

44.15%

40.35%

Operating Margin (?)

32.05%

38.12%

32.82%

27.60%

26.13%

Pretax Margin (?)

34.13%

39.35%

34.80%

29.43%

28.41%

Net Profit Margin (?)

28.39%

33.51%

29.72%

24.63%

24.69%

Financial Strength

Current Ratio (?)

2.99

5.39

1.47

1.47

1.45

Long Term Debt/Equity (?)

0.00

0.00

0.00

0.00

0.03

Total Debt/Equity (?)

0.01

0.00

0.05

0.00

0.07

Management Effectiveness

Return on Assets (?)

8.33%

13.09%

20.78%

17.45%

16.88%

Return on Equity (?)

11.00%

18.25%

53.27%

43.32%

41.55%

Efficiency

Receivables Turnover (?)

3.17

4.32

4.98

5.67

5.03

Inventory Turnover (?)

0.99

0.99

0.96

1.02

1.08

Asset Turnover (?)

0.29

0.39

0.70

0.68

0.69

Market Valuation USD (mil)

P/E (TTM) (?)

28.01

.

Enterprise Value2 (?)

743.0

Price/Sales (TTM) (?)

7.95

.

Enterprise Value/Revenue (TTM) (?)

5.64

Price/Book (MRQ) (?)

2.98

.

Enterprise Value/EBITDA (TTM) (?)

19.69

Market Cap as of 24-May-20131 (?)

1,065.3

.

 

 

1-ExchangeRate: CNY to USD on 24-May-2013

6.134850

 

 

 

2-ExchangeRate: CNY to USD on 31-Dec-2012

6.235700

 

 

 

 

 

Annual Ratios

 

Financials in: USD (mil) 

Except for share items (millions) and per share items (actual units)         

 

 

31-Dec-2012

31-Dec-2011

31-Dec-2010

31-Dec-2009

31-Dec-2008

Financial Strength

Current Ratio (?)

2.99

5.39

1.47

1.47

1.45

Quick/Acid Test Ratio (?)

2.37

4.47

0.75

0.77

0.67

Working Capital1 (?)

309.3

296.8

35.1

21.7

13.5

Long Term Debt/Equity (?)

0.00

0.00

0.00

0.00

0.03

Total Debt/Equity (?)

0.01

0.00

0.05

0.00

0.07

Long Term Debt/Total Capital (?)

0.00

0.00

0.00

0.00

0.03

Total Debt/Total Capital (?)

0.01

0.00

0.05

0.00

0.07

Payout Ratio (?)

-

43.24%

0.00%

0.00%

0.00%

Effective Tax Rate (?)

14.97%

14.02%

14.67%

13.45%

13.75%

Total Capital1 (?)

354.1

326.2

52.4

30.3

22.5

 

 

 

 

 

 

Efficiency

Asset Turnover (?)

0.29

0.39

0.70

0.68

0.69

Inventory Turnover (?)

0.99

0.99

0.96

1.02

1.08

Days In Inventory (?)

367.31

367.83

378.91

359.07

337.26

Receivables Turnover (?)

3.17

4.32

4.98

5.67

5.03

Days Receivables Outstanding (?)

115.28

84.51

73.22

64.34

72.50

Revenue/Employee2 (?)

-

139,314

106,630

96,834

90,814

Operating Income/Employee2 (?)

-

53,106

34,995

26,730

23,729

EBITDA/Employee2 (?)

-

54,953

36,529

28,416

25,495

 

 

 

 

 

 

Profitability

Gross Margin (?)

45.54%

48.13%

47.95%

44.15%

40.35%

Operating Margin (?)

32.05%

38.12%

32.82%

27.60%

26.13%

EBITDA Margin (?)

33.87%

39.45%

34.26%

29.35%

28.07%

EBIT Margin (?)

32.05%

38.12%

32.82%

27.60%

26.13%

Pretax Margin (?)

34.13%

39.35%

34.80%

29.43%

28.41%

Net Profit Margin (?)

28.39%

33.51%

29.72%

24.63%

24.69%

R&D Expense/Revenue (?)

5.69%

-

-

-

-

COGS/Revenue (?)

54.46%

51.87%

52.05%

55.85%

59.65%

SG&A Expense/Revenue (?)

11.98%

15.66%

15.17%

16.23%

16.17%

 

 

 

 

 

 

Management Effectiveness

Return on Assets (?)

8.33%

13.09%

20.78%

17.45%

16.88%

Return on Equity (?)

11.00%

18.25%

53.27%

43.32%

41.55%

 

 

 

 

 

 

Valuation

Free Cash Flow/Share2 (?)

0.23

-0.03

0.09

0.07

0.03

Operating Cash Flow/Share 2 (?)

0.27

0.09

0.12

0.11

0.05

1-ExchangeRate: CNY to USD Period End Date

6.2357

6.294

6.5897

6.827

6.823

2-ExchangeRate: CNY to USD Average for Period

6.2357

6.294

6.5897

6.827

6.823

 

Current Market Multiples

Market Cap/Earnings (TTM) (?)

28.01

Market Cap/Equity (MRQ) (?)

2.98

Market Cap/Revenue (TTM) (?)

7.95

Market Cap/EBIT (TTM) (?)

29.59

Market Cap/EBITDA (TTM) (?)

29.59

Enterprise Value/Earnings (TTM) (?)

19.86

Enterprise Value/Equity (MRQ) (?)

2.12

Enterprise Value/Revenue (TTM) (?)

5.64

Enterprise Value/EBIT (TTM) (?)

20.98

Enterprise Value/EBITDA (TTM) (?)

20.98


 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.56.74

UK Pound

1

Rs.88.53

Euro

1

Rs.75.20

 

INFORMATION DETAILS

 

Report Prepared by :

SDA

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

----

NB

New Business

----

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.